Two decades of hepatitis B infections among drug users in Amsterdam: Are they still a high-risk group?

2009 ◽  
Vol 81 (7) ◽  
pp. 1163-1169 ◽  
Author(s):  
Robin van Houdt ◽  
Charlotte H.S.B. van den Berg ◽  
Ineke G. Stolte ◽  
Sylvia M. Bruisten ◽  
Nicole H.T.M. Dukers ◽  
...  
Keyword(s):  
High Risk ◽  
Hepatitis B ◽  
Drug Users ◽  
Risk Group ◽  
High Risk Group

P.029 Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group?

2009 ◽  
Vol 44 ◽  
pp. S23
Author(s):  
R. van Houdt ◽  
C.H.S.B. Berg ◽  
I.G. Stolte ◽  
S.M. Bruisten ◽  
N.H.T.M. Dukers ◽  
...  
Keyword(s):  
High Risk ◽  
Hepatitis B ◽  
Drug Users ◽  
Risk Group ◽  
High Risk Group

scholarly journals Prevalence of hepatitis B and hepatitis C among intravenous drug abusers in the Lebanese population

2018 ◽  
Vol 12 (02.1) ◽  
pp. 28S
Author(s):  
Mary Nakhoul ◽  
Carine Richa ◽  
Afif Jreij ◽  
Antoine Abou Rached
Keyword(s):  
Public Health ◽  
Hepatitis C ◽  
High Risk ◽  
Hepatitis B ◽  
Risk Group ◽  
Rapid Test ◽  
High Risk Group ◽  
High Rate ◽  
Health Concern ◽  
Public Health Concern

Introduction: Injection drug users (IVDU) are prone to many blood born viral infections. Hepatitis B virus (HBV) and Hepatitis C virus (HCV) constitute an important public health concern in this high-risk group. The aim of the study is to calculate the prevalence of hepatitis B and C viruses among people who inject drugs (PWID) in Lebanon. Methodology: We conducted a prospective cross-sectional study between June 2015 and June 2016 on PWIDs recruited through the Lebanese non-governmental organizations in collaboration with the Lebanese ministry of public health. The participants were tested for HBs Antigen and HCV antibody using rapid test kits. The prevalence of each virus was then calculated. The correlation between both infections and other possible risk factors was also analyzed. Results: A total of 250 people were included in our study. 98% were males. Mean age was 31.9-year-old. The prevalence of HBV and HCV among PWID was 1.2% and 15.6%, respectively. Older age, longer duration of drug use, and the lack of awareness were found to be significantly correlated with higher rate of HCV infection. We noted a relatively high rate of sharing needles among PWIDs without significantly affecting the prevalence of both viruses. Conclusion: IVDU remains a major public health concern in Lebanon, being one of the most prevalent subpopulations for chronic viral hepatitis namely the HCV. Appropriate screening strategies, targeted educational programs and adequate HBV vaccination are of extreme importance for further viral prevention among this high-risk group.

Long-term efficacy of the hepatitis B Vaccine in a high-risk group

2013 ◽  
Vol 85 (9) ◽  
pp. 1518-1522 ◽  
Author(s):  
Sarah S. Al Ghamdi ◽  
Hind I. Fallatah ◽  
Dina M. Fetyani ◽  
Jamil A. Al-Mughales ◽  
Abdulhadi T. Gelaidan
Keyword(s):  
High Risk ◽  
Hepatitis B ◽  
Risk Group ◽  
High Risk Group ◽  
Hepatitis B Vaccine ◽  
Term Efficacy

Intravenous drug users - a new high-risk group for HIV infection in India

AIDS ◽  
1991 ◽  
Vol 5 (1) ◽  
pp. 117-118 ◽  
Author(s):  
T. N. Naik ◽  
S. Sarkar ◽  
HI Singh ◽  
S. C. Bhunia ◽  
Y. I. Singh ◽  
...  
Keyword(s):  
High Risk ◽  
Hiv Infection ◽  
Drug Users ◽  
Risk Group ◽  
High Risk Group ◽  
Intravenous Drug ◽  
Intravenous Drug Users

Acromegaly and Obstructive Sleep Apnea: Identifying the High-Risk Group

2019 ◽  
Author(s):  
Xiaojun Zhan ◽  
Chandala Chitguppi ◽  
Ethan Berman ◽  
Gurston Nyquist ◽  
Tomas Garzon-Muvdi ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
High Risk ◽  
Risk Group ◽  
High Risk Group ◽  
Obstructive Sleep
Sign in / Sign up

Export Citation Format

Share Document